A multicentre, randomized, double-blind, parallel-group, controlled study, to assess the efficacy and safety of P-3074 cutaneous spray, solution, in the treatment of male pattern baldness.

Trial Profile

A multicentre, randomized, double-blind, parallel-group, controlled study, to assess the efficacy and safety of P-3074 cutaneous spray, solution, in the treatment of male pattern baldness.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 May 2017

At a glance

  • Drugs Finasteride (Primary) ; Finasteride (Primary)
  • Indications Alopecia
  • Focus Registrational; Therapeutic Use
  • Sponsors Polichem
  • Most Recent Events

    • 09 May 2017 Planned End Date changed from 1 Sep 2017 to 1 Feb 2018.
    • 09 May 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Feb 2018.
    • 23 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top